States are now taking action to track gabapentin use through prescription monitoring programs, and some states have reclassified it as a Schedule V controlled substance. Media Contact: LARA Communications 517-373-9280 Email: mediainfo@michigan.gov January 9, 2019 – In an effort to continue to combat the opioid epidemic in Michigan, the Dept. of Licensing and Regulatory Affairs (LARA), with the support of the Michigan Board of Pharmacy, has modified its Pharmacy Rules to categorize Gabapentin as a Schedule 5 controlled substance. Gabapentin grew to 64 million prescriptions in the United States in 2016 from 39 million prescriptions in 2012, 12 making it the 10th most prescribed medication that year. 13 Gabapentin has been widely recognized as a drug related to opioid abuse in West Virginia. 14 Studies have shown that gabapentin in toxicology reports constituted a Eight states have made gabapentin a schedule V controlled substance. And 12 other states require stricter reporting on gabapentin prescriptions. If you have a prescription for gabapentin, it’s best to take the lowest dose possible. While gabapentin is NOT considered as a controlled substance on a federal level, there are some states that reclassified the drug as a controlled substance. The five states that have reclassified gabapentin as a controlled substance are Kentucky, Virginia, West Virginia, Michigan, and Tennessee. In the state of Kentucky, prescribers without a DEA license are unable to prescribe gabapentin after it was classified as a Schedule V controlled substance. 38 This licensing requirement is part of the state’s Controlled Substances Act which had the greatest impact on mid-level practitioners who may not have a DEA license. Kentucky While gabapentin remains a non-controlled substance, Session Law 2023-65 Part XI Section 11.1 G.S. 90-113.73(b) adds it to the medications recorded in NC CSRS because it may cause a level of sedation in patients that puts them at increased risk of overdose when taken with opioids. The NC Department of Health and Human Services (NCDHHS) has Twelve states have not classified gabapentin as a controlled substance, but require gabapentin dispensing must be reported to their PMP (including CT, DC, IN, KS, MA, MN, NE, NJ, OH, OR, UT, and WY). Gabapentin isn’t a narcotic or federally controlled substance, but it is regulated and recognized as a controlled substance in certain states. Gabapentin is approved by the Food and Drug Gabapentin is not currently listed as a controlled substance under the Controlled Substances Act of 1970.11 Several state boards of pharmacy, as outlined in Supplemental Table 2 and Figure 1, have independently reclassified gabapentin under state pharmacy rules as a Schedule V drug. Other states have required gabapentin use to be monitored Is Gabapentin a Controlled Substance in All 50 States? No, as of 2022, gabapentin is a Schedule V controlled substance in Alabama, Kentucky, Michigan, North Dakota, Tennessee, Virginia, and West Virginia. Some states classify it as a Schedule V controlled substance due to concerns about misuse and its involvement in the opioid crisis. Others do not schedule it but require mandatory reporting to state prescription drug monitoring programs (PDMPs) to track prescribing and dispensing. In this comprehensive guide, we discuss whether or not gabapentin is considered a controlled substance in different states across the U.S., as well as its possible side effects and dangers if misused or abused. Gabapentin is not currently listed as a controlled substance under federal law. However, some states classify gabapentin as a Schedule V substance or a drug of concern and mandate reporting to PMP. Furthermore, other states are considering similar actions due to increasing evidence of associated risks. Gabapentin (Neurontin) is not a narcotic or federally controlled substance by the DEA as of November 2022, but it is classified as a Schedule V controlled substance in certain states. Gabapentin is not currently listed as a controlled substance under the Controlled Substances Act of 1970. 11 Several state boards of pharmacy, as outlined in Supplemental Table 2 and Figure 1, have independently reclassified gabapentin under state pharmacy rules as a Schedule V drug. Other states have required gabapentin use to be monitored To date, seven US states (AL, KY, MI, ND, TN, VA, and WV) have classified gabapentin as a controlled substance. In a petition filed with the DEA and the US Food and Drug Administration (FDA) in February, the nonprofit advocacy group Public Citizen called for making that regulation federal, in an effort to stop increasing abuse and diversion. The annual total prescriptions dispensed for gabapentin in the United States steadily increased by approximately 150% over the past 15 years. According to the IQVIA National Prescription Audit™, total prescriptions dispensed for gabapentin nited States were in the U approximately 29.6 million in 2010, 56.9 million in 2015, 69.0 million in States are now taking action to track gabapentin use through prescription monitoring programs, and some states have reclassified it as a Schedule V controlled substance. This commentary summarizes gabapentin's abuse potential, identifies state-level actions regarding gabapentin monitoring, and discusses possible clinical implications and ways
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |